The funding will be directed towards the research and production of biologics and biosimilar medicinesPublished Mon, Feb 2, 2026 · ...
The group intends to raise at least S$5 million from the exercise, with new shares issued at S$0.10 apiece Singapore-based ...
The placement price represents a discount of 9.7% to the volume weighted average price (VWAP) of S$0.1107 per share Mainboard-listed ...
The placement price represents a discount of 9.7% to the volume weighted average price (VWAP) of S$0.1107 per share Mainboard-listed ...
Shares of Singapore-based speciality pharmaceutical and nutraceutical company iX Biopharma jumped 35.1 per cent to S$0.127 on Monday (Oct 27). This ...
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in ...
The world is full of brilliant minds who push the boundaries of knowledge. It is remarkable when they commit to ...
Patients are flocking to the region in search of good quality, alternative healthcare treatments, while biopharma firms are making forays ...
The Federal Trade Commission filed suit to block a $28 billion biopharma merger, saying the deal would harm consumers AFP ...
